<- Go Home
TearLab Corporation
TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. The company offers TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab Pen, a hand-held device that interfaces with the TearLab disposable; and TearLab Reader, a small desktop unit that allows for the docking of the TearLab Pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in Southlake, Texas.
Market Cap
$1.4M
Volume
34.6K
Cash and Equivalents
$7.3M
EBITDA
$767.3K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$14.3M
Profit Margin
64.76%
52 Week High
$0.21
52 Week Low
$0.02
Dividend
N/A
Price / Book Value
-0.03
Price / Earnings
-0.13
Price / Tangible Book Value
-0.03
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$128.0K
Return on Equity
22.78%
Return on Assets
0.54
Cash and Short Term Investments
$7.3M
Debt
$38.6M
Equity
-$27.6M
Revenue
$22.1M
Unlevered FCF
-$578.7K
Sector
Health Care Equipment and Supplies
Category
N/A